Regulation of mitochondrial morphology by positive feedback interaction between PKCδ and Drp1 in vascular smooth

Soyeon Lim1, Se-Yeon Lee, Hyang-Hee Seo

  • 1Severance Integrative Research Institute for Cerebral & Cardiovascular Disease, Yonsei University Health System, Seodaemun-gu, Seoul, 120-752, Republic of Korea.

Insights

Dynamin-related protein-1 (Drp1) inhibition prevents vascular smooth muscle cell proliferation and migration, offering a potential therapeutic strategy for restenosis and atherosclerosis by targeting mitochondrial dynamics.

Area of Science:

  • Mitochondrial dynamics and cell signaling in cardiovascular disease.

Background:

  • Dynamin-related protein-1 (Drp1) regulates mitochondrial fission, impacting cell proliferation.
  • Drp1's role in vascular smooth muscle cell (vSMC) responses to stimuli like Angiotensin II (Ang II) and hydrogen peroxide (H2O2) is not well understood.
  • Mdivi-1, a Drp1 inhibitor, shows potential in attenuating proliferation.

Purpose of the Study:

  • To investigate the hypothesis that Drp1 inhibition prevents vascular restenosis.
  • To elucidate the molecular mechanisms underlying Drp1's role in vSMC proliferation and migration under pathological conditions.

Main Methods:

  • In vitro assays for vSMC migration and proliferation.
  • Assessment of reactive oxygen species (ROS) production and mitochondrial membrane potential.
  • Ex vivo aortic ring assays and in vivo rat carotid artery balloon injury models.
  • Analysis of Drp1 interaction with PKCδ and downstream signaling pathways (MEK1/2-ERK1/2, MMP2).

Main Results:

  • Drp1 inhibition, specifically reducing Drp1 Ser 616 phosphorylation, attenuated Ang II/H2O2-induced vSMC proliferation and migration.
  • Drp1 inhibition mitigated excessive ROS production and preserved mitochondrial membrane potential.
  • Activated Drp1 interacted with PKCδ, leading to MEK1/2-ERK1/2 and MMP2 activation under Ang II stimulation.
  • Mdivi-1 demonstrated significant anti-proliferative and anti-migratory effects in vitro, ex vivo, and in vivo, preventing neointima formation after balloon injury.

Conclusions:

  • Drp1 plays a crucial role in pathological vSMC proliferation and migration.
  • Inhibition of Drp1, via Mdivi-1, effectively prevents vascular restenosis and neointima formation.
  • Drp1 emerges as a promising therapeutic target for treating restenosis and atherosclerosis.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.5K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
4.0K
Mitochondrial Membranes01:45

Mitochondrial Membranes

A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
18.1K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.2K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
8.0K